3-iodobenzylguanidine has been researched along with 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (10.71) | 29.6817 |
2010's | 19 (67.86) | 24.3611 |
2020's | 6 (21.43) | 2.80 |
Authors | Studies |
---|---|
Bennink, R; Booij, J; Busemann Sokole, E; de Bruin, K; Habraken, JB; Shehata, M; van Eck Smit, BL | 1 |
Becker, G; Dillmann, U; Fuss, G; Jost, WH; Kirsch, CM; Möllers, MO; Samnick, S; Spiegel, J | 1 |
Arabia, G; Bagnato, A; Cascini, GL; Condino, F; Giofrè, L; Messina, D; Morelli, M; Nicoletti, G; Novellino, F; Paglionico, S; Quattrone, A; Restuccia, A; Salsone, M; Torchia, G | 1 |
Alvés, L; Artigas, C; Blesa, R; Camacho, V; Carrió, I; Duch, J; Estorch, M; Flotats, A; Gómez-Isla, T; Lleó, A; Marquié, M | 1 |
Chung, SW; Kim, JS; Kim, YD; Lee, KS; Oh, YS | 1 |
Antke, C; Beu, M; Müller, HW; Nikolaus, S; Schnitzler, A; Südmeyer, M; Wojtecki, L; Zizek, T | 1 |
Labate, A; Quattrone, A; Salsone, M | 1 |
Buongiorno, MT; Compta, Y; Gaig, C; Lomeña, F; Martí, MJ; Muxi, A; Navarro-Otano, J; Tolosa, E; Valldeoriola, F | 1 |
Choi, EK; Chung, YA; Kim, JS; Oh, JK; Song, IU | 1 |
Asahi, T; Kashiwazaki, D; Kuroda, S; Noguchi, K; Yoneyama, T | 1 |
Hida, A; Kameyama, M; Morooka, M; Sato, K; Takeuchi, S | 1 |
Iikuni, Y; Ito, H; Kang, Y; Morimatsu, A; Murakami, T; Shirata, A; Ugawa, Y; Yamada, A; Yamane, K | 1 |
Antelmi, L; Biffi, AM; Calcagni, ML; Capitanio, S; Cecchin, D; Corso, A; Gabanelli, SV; Guerra, UP; Merello, M; Micheli, A; Muscio, C; Nobili, F; Piccardo, A; Pinto, P; Riva, R; Sacco, L; Stefanini, S; Tettamanti, M; Tiraboschi, P; Vai, P; Vidale, S; Volterrani, D | 1 |
Abe, K; Hatanaka, N; Hishikawa, N; Matsuzono, K; Ohta, Y; Sato, K; Takamatsu, K; Takemi, T; Takemoto, M; Tsunoda, K; Yamashita, T | 1 |
Boccardi, M; Herholz, K; Nobili, F; Picco, A; Ratib, O; Sonni, I; Varrone, A | 1 |
Baba, Y; Hashimoto, J; Koide, T; Ryo, M; Yoshii, F | 1 |
Harada, M; Izumi, Y; Kaji, R; Kunikane, Y; Otomi, Y; Otsuka, H; Sako, W; Shinya, T; Takashi, S; Uyama, N; Watanabe, Y | 1 |
Hikichi, C; Hirota, S; Ishikawa, T; Ito, S; Maeda, T; Mizutani, Y; Murate, K; Mutoh, T; Nagao, R; Niimi, Y; Shima, S; Ueda, A | 1 |
Galleri, G; Madeddu, G; Mulas, A; Nieddu, A; Nuvoli, S; Piras, MR; Rocchitta, G; Serra, PA; Spanu, A | 1 |
Hashimoto, J; Kohara, S; Moriya, Y; Ohnuki, T; Ryo, M; Takahashi, W; Yoshii, F | 1 |
Hasegawa, Y; Maki, F; Nakamura, H; Nakashima, Y; Okada, Y; Sasaki, N; Sasaki, O; Shiraishi, M | 1 |
Koh, K; Nagasaka, T; Shindo, K; Takiyama, Y; Tsuchiya, M | 1 |
Cheon, SM; Jeong, JE; Jeong, YJ; Kang, DY; Kim, JW; Yoon, BA | 1 |
Boura, I; Bourogianni, O; Kapsoritakis, N; Koukouraki, S; Mitsias, P; Papadaki, E; Simos, P; Spanaki, C; Stathaki, M; Tsaroucha, A | 1 |
Ali, T; Allan, L; Barker, S; Barnett, N; Ciafone, J; Colloby, SJ; Donaghy, PC; Durcan, R; Firbank, MJ; Hamilton, CA; Howe, K; Lawley, S; Lloyd, J; O'Brien, J; Petrides, GS; Roberts, G; Taylor, JP; Thomas, AJ | 1 |
An, YS; Chang, J; Kang, J; Park, DG; Yoon, JH | 1 |
An, YS; Kim, MS; Park, DG; Yoon, JH | 1 |
Carli, G; Janzen, A; Kogan, RV; Leenders, KL; Meles, SK; Oertel, WH; Perani, D; Sittig, E | 1 |
1 review(s) available for 3-iodobenzylguanidine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
Article | Year |
---|---|
Clinical validity of presynaptic dopaminergic imaging with
Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Nortropanes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2017 |
1 trial(s) available for 3-iodobenzylguanidine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
Article | Year |
---|---|
Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Benzamides; Diagnosis, Differential; Humans; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Radionuclide Imaging; ROC Curve; Sensitivity and Specificity; Tropanes | 2011 |
26 other study(ies) available for 3-iodobenzylguanidine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
Article | Year |
---|---|
Evaluation of high-resolution pinhole SPECT using a small rotating animal.
Topics: 3-Iodobenzylguanidine; Animals; Calibration; Cricetinae; Feasibility Studies; Iodine Radioisotopes; Mice; Phantoms, Imaging; Radiopharmaceuticals; Rats; Tomography, Emission-Computed, Single-Photon; Tropanes | 2001 |
FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Brain; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2005 |
Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Male; Middle Aged; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tremor; Tropanes | 2009 |
Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Female; Heart Diseases; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Striatonigral Degeneration; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Tropanes | 2011 |
Camptocormia: as the first sign of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Female; Humans; Muscular Atrophy, Spinal; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Curvatures; Tropanes | 2011 |
Cardiac denervation precedes nigrostriatal damage in idiopathic rapid eye movement sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Corpus Striatum; Heart; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Substantia Nigra; Sympathectomy; Tomography, Emission-Computed, Single-Photon; Tropanes | 2012 |
123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Smell; Tomography, Emission-Computed, Single-Photon; Tropanes | 2014 |
Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2015 |
Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Deep Brain Stimulation; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Nortropanes; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2016 |
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Brain; Chorea; Corpus Striatum; Cysteine; Diabetes Complications; Diabetes Mellitus; Dopamine; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neostriatum; Nortropanes; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2016 |
[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Disease Progression; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Nortropanes; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2016 |
(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Corpus Striatum; Diagnosis, Differential; Female; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2016 |
Potential multisystem degeneration in Asidan patients.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Family; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Pedigree; Radiopharmaceuticals; Spinocerebellar Degenerations; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
Combined use of dopamine transporter imaging (DAT-SPECT) and
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Severity of Illness Index; Statistics as Topic; Tropanes | 2017 |
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; ROC Curve; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
Usefulness of combining
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Protein Binding; Retrospective Studies; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nortropanes; Parkinsonian Disorders; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2017 |
Topics: 3-Iodobenzylguanidine; Adult; Aftercare; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Logistic Models; Male; Middle Aged; Nortropanes; Parkinson Disease; Radionuclide Imaging; Sensitivity and Specificity | 2018 |
Decreasing
Topics: 3-Iodobenzylguanidine; Adult; Brain; Carrier Proteins; Diagnosis, Differential; Female; Heart; Homozygote; Humans; Mutation; Myocardial Perfusion Imaging; Nortropanes; Radiopharmaceuticals; Spastic Paraplegia, Hereditary; Tomography, Emission-Computed, Single-Photon | 2019 |
Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Pressure; Female; Fluorine Radioisotopes; Heart; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Parkinson Disease; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tropanes | 2020 |
Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Nortropanes; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2020 |
Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2021 |
Association of plasma α-synuclein with cardiac
Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tropanes | 2022 |
Dual-phase
Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Glucosylceramidase; Humans; Hypotension, Orthostatic; Mutation; Parkinson Disease; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon; Tropanes | 2023 |
Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Risk Factors | 2023 |